CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-01 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −4,630 | 23,148 | ||
| 2020-12-01 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −2,315 | 46,296 | ||
| 2020-11-27 | Pang Phillip Chief Medical Officer | Option exercise | +7,500 | $0.86 | $6K | 57,277 |
| 2020-11-27 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −7,500 | 53,833 | ||
| 2020-11-27 | Virgin Herbert EVP, Research & CSO | Option exercise | +2,930 | $1.53 | $4K | 26,630 |
| 2020-11-27 | Virgin Herbert EVP, Research & CSO | Sale | −2,930 | $30.00 | $88K | 23,700 |
| 2020-11-27 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −2,930 | 442,900 | ||
| 2020-11-24 | Virgin Herbert EVP, Research & CSO | Option exercise | +2,340 | $1.53 | $4K | 26,040 |
| 2020-11-24 | Virgin Herbert EVP, Research & CSO | Sale | −2,340 | $27.29 | $64K | 23,700 |
| 2020-11-24 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −2,340 | 445,830 | ||
| 2020-11-12 | Pang Phillip Chief Medical Officer | Option exercise | +20,000 | $0.86 | $17K | 49,777 |
| 2020-11-12 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −20,000 | 61,333 | ||
| 2020-11-10 | Virgin Herbert EVP, Research & CSO | Option exercise | +2,340 | $1.53 | $4K | 26,040 |
| 2020-11-10 | Virgin Herbert EVP, Research & CSO | Sale | −2,340 | $26.26 | $61K | 23,700 |
| 2020-11-10 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −2,340 | 448,170 | ||
| 2020-11-04 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $1.53 | $8K | 34,777 |
| 2020-11-02 | Parrish Jay Chief Business Officer | Option exercise | +4,629 | $1.49 | $7K | 226,851 |
| 2020-11-02 | Parrish Jay Chief Business Officer | Option exercise | +2,315 | $1.58 | $4K | 229,166 |
| 2020-11-02 | Parrish Jay Chief Business Officer | Sale | −6,944 | $31.27 | $217K | 222,222 |
| 2020-11-02 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −4,629 | 27,778 |
Page 48 of 54 · 1,063 trades